Aviva’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Aviva’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-17,197	Closed	-$2.34M	–	917
2020 Q3	$2.34M	Sell	17,197 -6,405	-27%	-$681K	0.01%	659
2020 Q2	$2.28M	Sell	23,602 -46,519	-66%	-$3.88M	0.01%	722
2020 Q1	$3.29M	Buy	70,121 +37,223	+113%	+$2.39M	0.02%	635
2019 Q4	$2.4M	Buy	+32,898	New	+$2M	0.01%	633

Aviva's MYOK Position: Q4 2020 in Review

Aviva sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 17,197 shares — an estimated $2.34M sold.

Aviva first reported a position in MYOK in Q4 2019 and held it in 4 quarters. The position peaked at $3.29M in Q1 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Aviva reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Aviva sold 17,197 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $2.34M.
Aviva first reported a position in MyoKardia, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
Aviva's MyoKardia, Inc. Common Stock position peaked at $3.29M in Q1 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Aviva's 13F filing for Q4 2020, filed 10 Feb 2021.